Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKRX

Akorn (AKRX) Stock Price, News & Analysis

Akorn logo

About Akorn Stock (NASDAQ:AKRX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.09
$0.32
52-Week Range
N/A
Volume
1.19 million shs
Average Volume
9.60 million shs
Market Capitalization
$3.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akorn and its competitors with MarketBeat's FREE daily newsletter.

AKRX Stock News Headlines

Akorn Reaches New 52-Week High (AKRX)
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
See More Headlines

AKRX Stock Analysis - Frequently Asked Questions

Akorn, Inc. (NASDAQ:AKRX) released its quarterly earnings data on Monday, May, 11th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.45. The business earned $204.69 million during the quarter, compared to analysts' expectations of $168.90 million. Akorn had a positive trailing twelve-month return on equity of 8.53% and a negative net margin of 55.64%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akorn investors own include Bristol Myers Squibb (BMY), Integrated Device Technology (IDTI), Skechers U.S.A. (SKX), Rite Aid (RAD), Lannett (LCI), Bank of America (BAC) and Quantenna Communications (QTNA).

Company Calendar

Last Earnings
5/11/2020
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:AKRX
CIK
3116
Fax
N/A
Employees
2,227
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$226.77 million
Net Margins
-55.64%
Pretax Margin
N/A
Return on Equity
8.53%
Return on Assets
1.31%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
0.50
Quick Ratio
0.32

Sales & Book Value

Annual Sales
$682.43 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.19
Book Value
$1.86 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
133,152,000
Free Float
N/A
Market Cap
$3.60 million
Optionable
Optionable
Beta
0.95
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:AKRX) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners